NIVATROTAMAB
UNII 8RV18E4A94

Substance Identification & Data

This profile provides standardized clinical and technical data for Nivatrotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8RV18E4A94.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2278244-14-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8RV18E4A94

CAS Registry Number

2278244-14-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NIVATROTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C158436

National Cancer Institute reference terminology for clinical and research data.

INN ID

11591

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nivatrotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NIVATROTAMAB

Common Names & Synonyms

IMMUNOGLOBULIN, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL 3F8 .KAPPA.-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (TS(GGGGS)3) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL OKT3 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)6-VK), DISULFIDE WITH (299-ALANINE,324-ALANINE) HUMAN-MUS MUSCULUS MONOCLONAL 3F8 .GAMMA.1-CHAIN, DIMER

NIVATROTAMAB [INN]

NIVATROTAMAB [USAN]